非对称二甲基精氨酸与血管内皮功能障碍临床研究
被引量：2
摘要
非对称性二甲基精氨酸(ADMA)是一个内源性一氧化氮合成酶抑制剂,它通过抑制一氧化氮的产生,损伤血管内皮细胞,加速动脉粥样硬化的进程。在动脉粥样硬化患者和具有动脉粥样硬化高危因素的患者血浆中ADMA水平增高,并且与内皮功能不全和动脉粥样硬化程度具有明显的相关性。ADMA成为一个新的血管内皮功能障碍相关疾病的危险因子。
出处
《国际心血管病杂志》
2007年第5期333-337,共5页
International Journal of Cardiovascular Disease
基金
安徽省教育厅自然研究科学研究项目(2006KJ398B)
参考文献26
-
1[1]Schulze F,Lenzen H,Hanefeld C,et al.Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study[J].Am Heart J,2006,152 (3):493.e1-e8.
-
2[2]Yilmaz MI,Saglam M,Caglar K,et al.The determinants of endothelial dysfunction in CKD:oxidative stress and asymmetric dimethylarginine[J].Am J Kidney Dis,2006,47(1):42-50.
-
3[3]Jiang X,Yang F,Tan H,et al.Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation[J].Arterioscler Thromb Vasc Biol,2005,25 (12):2515-2521.
-
4[4]Kumagai H,Sakurai M,Takita T,et al.Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients[J].Am J Kidney Dis,2006,48(5):797-805.
-
5[5]Caglar K,Yilmaz MI,Sonmez A,et al.ADMA,proteinuria,and insulin resistance in non-diabetic stage I chronic kidney disease[J].Kidney Int,2006,70(4):781-787.
-
6[6]Aslam S,Santha T,Leone A,et al.Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis[J].Kidney Int,2006,70(12):2109-2015.
-
7[7]Zoccali C.Asymmetric dimethylarginine (ADMA):a cardiovascular and renal risk factor on the move[J].J Hypertens,2006,24(4):611-619.
-
8[8]Kumagai H,Sakurai M,Takita T,et al.Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients[J].Am J Kidney Dis,2006,48(5):797-805.
-
9[9]Jiang JL,Zhang XH,Li NS,et al.Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity[J].Cardiovasc Drugs Ther,2006,20(4):281-294.
-
10[10]Westphal S,Borucki K,Luley C,et al.Treatment with niacin lowers ADMA[J].Atherosclerosis,2006,184 (2):448-450.
同被引文献26
-
1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
-
2Boger RH, Sullivan LM, Schwedhelm E, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community[J]. Circulation, 2009,119 (12) ,1592-1600.
-
3Vladimirova-Kitova L, Deneva T, Angelova E, et al. Relationship of asymmetric dimethylarginine with flow- mediated dilatation in subjects with newly detected severe hypercholesterolemia[J]. Clin Physiol Funct Imaging, 2008,28 (6) :417-425.
-
4Schmitt B, Wolters M, Kressel G, et al. Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethy larginine (ADMA) in subjects with elevated risk for cardiovascular disease [ J]. Atherosclerosis, 2007,193 ( 1 ) : 168-176.
-
5卜云涛,边波,万征.非对称性二甲基精氨酸和冠状动脉性心脏病及其危险因素的关系[J].中国循环心血管医学杂志,2011,3(1):63-66.
-
6Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA [J]. Vase Med,2008,10 (Suppl 1) :S35-43.
-
7Stuhlinger MC, Abbasi F,Chu JW, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor[J]. JAMA,2009,287(11) : 1420-1426.
-
8Abbasi F, Asagmi T,Cooke JP,et al. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus[J]. Am J Cardiol,2007,88(10) : 1201- 1203.
-
9Pleiner J, Mittermayer F, Langenberger H, et al. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes[J]. Wien Klin Wochenschr, 2007,119 ( 15/ 16) :483-489.
-
10Krzyzanowska K, Mittermayer F, Wolzt M, et al. Asymmetric dimetbylarginine predicts cardiovascular events in patients with type 2 diabetes[J]. Diabetes Care,2007,30(7) :1834-1839.
-
1MarkusC.Sttihlinger,MD FahimAbbasi,MD JamesW.Chu,MD CindyLamendola,MSN,ANP TraceyLMcLaughlin,MD JohnP.Cooke,MD,PhD GeraldM.Reaven,MD PhilipS.Tsao,PhD 金雪娟 诸骏仁.胰岛素抵抗与内源性一氧化氮合成酶抑制剂[J].美国医学会杂志（中文版）,2003,22(4):191-196. 被引量：1
